ID

28026

Description

Metabolic Effects of Paricalcitol; ODM derived from: https://clinicaltrials.gov/show/NCT01003275

Lien

https://clinicaltrials.gov/show/NCT01003275

Mots-clés

Versions (1)
  1. 11/12/2017 11/12/2017 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

11 décembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Chronic Kidney Disease NCT01003275

Anglais

Eligibility Chronic Kidney Disease NCT01003275

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
estimated glomerular filtration rate of 15-59 ml/min/1.73m2
Description

Estimated Glomerular Filtration Rate

Type de données

boolean

Alias
UMLS CUI [1]
C3811844
fasting glucose 100-125 mg/dl
Description

Glucose measurement, fasting

Type de données

boolean

Alias
UMLS CUI [1]
C0202045
18 years and older
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
diagnosed with diabetes mellitus
Description

Diabetes Mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0011849
use of diabetes medications (insulin or oral hypoglycemics)
Description

Taking medication for diabetes | Insulin | Oral hypoglycemic

Type de données

boolean

Alias
UMLS CUI [1]
C2054148
UMLS CUI [2]
C0021641
UMLS CUI [3]
C0359086
prior dialysis or transplantation
Description

Dialysis | Transplantation

Type de données

boolean

Alias
UMLS CUI [1]
C0011946
UMLS CUI [2]
C0040732
planning to leave the area within 6 months
Description

Relocation of home Planned

Type de données

boolean

Alias
UMLS CUI [1,1]
C2699029
UMLS CUI [1,2]
C1301732
participation in another clinical trial within 30 days
Description

Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
treatment with paricalcitol, calcitriol, or corticosteroids in the preceding 8 weeks
Description

paricalcitol | Calcitriol | Adrenal Cortex Hormones

Type de données

boolean

Alias
UMLS CUI [1]
C0249582
UMLS CUI [2]
C0006674
UMLS CUI [3]
C0001617
serum calcium more than 10.2 mg/dl
Description

Serum calcium measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0728876
pregnancy or breast-feeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
change in dose (within 8 weeks) of fibrates, niacin, ace inhibitors, angiotensin receptor blockers, thiazide diuretics, beta-blockers, cholecalciferol or ergocalciferol
Description

Fibrates Dose changed | Niacin Dose changed | Angiotensin-Converting Enzyme Inhibitors Dose changed | Angiotensin II receptor antagonist Dose changed | Thiazide Diuretics Dose changed | Adrenergic beta-Antagonists Dose changed | Cholecalciferol Dose changed | Ergocalciferol Dose changed

Type de données

boolean

Alias
UMLS CUI [1,1]
C1449704
UMLS CUI [1,2]
C1608430
UMLS CUI [2,1]
C0027996
UMLS CUI [2,2]
C1608430
UMLS CUI [3,1]
C0003015
UMLS CUI [3,2]
C1608430
UMLS CUI [4,1]
C0521942
UMLS CUI [4,2]
C1608430
UMLS CUI [5,1]
C0012802
UMLS CUI [5,2]
C1608430
UMLS CUI [6,1]
C0001645
UMLS CUI [6,2]
C1608430
UMLS CUI [7,1]
C0008318
UMLS CUI [7,2]
C1608430
UMLS CUI [8,1]
C0014695
UMLS CUI [8,2]
C1608430
incontinent of urine
Description

Urinary Incontinence

Type de données

boolean

Alias
UMLS CUI [1]
C0042024
cancer (other than skin cancer) within 5 years
Description

Malignant Neoplasms | Exception Skin carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
tuberculosis
Description

Tuberculosis

Type de données

boolean

Alias
UMLS CUI [1]
C0041296
sarcoidosis
Description

Sarcoidosis

Type de données

boolean

Alias
UMLS CUI [1]
C0036202
Retour au début de la page

Similar models

Eligibility Chronic Kidney Disease NCT01003275

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Estimated Glomerular Filtration Rate
Item
estimated glomerular filtration rate of 15-59 ml/min/1.73m2
boolean
C3811844 (UMLS CUI [1])
Glucose measurement, fasting
Item
fasting glucose 100-125 mg/dl
boolean
C0202045 (UMLS CUI [1])
Age
Item
18 years and older
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus
Item
diagnosed with diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Taking medication for diabetes | Insulin | Oral hypoglycemic
Item
use of diabetes medications (insulin or oral hypoglycemics)
boolean
C2054148 (UMLS CUI [1])
C0021641 (UMLS CUI [2])
C0359086 (UMLS CUI [3])
Dialysis | Transplantation
Item
prior dialysis or transplantation
boolean
C0011946 (UMLS CUI [1])
C0040732 (UMLS CUI [2])
Relocation of home Planned
Item
planning to leave the area within 6 months
boolean
C2699029 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Study Subject Participation Status
Item
participation in another clinical trial within 30 days
boolean
C2348568 (UMLS CUI [1])
paricalcitol | Calcitriol | Adrenal Cortex Hormones
Item
treatment with paricalcitol, calcitriol, or corticosteroids in the preceding 8 weeks
boolean
C0249582 (UMLS CUI [1])
C0006674 (UMLS CUI [2])
C0001617 (UMLS CUI [3])
Serum calcium measurement
Item
serum calcium more than 10.2 mg/dl
boolean
C0728876 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Fibrates Dose changed | Niacin Dose changed | Angiotensin-Converting Enzyme Inhibitors Dose changed | Angiotensin II receptor antagonist Dose changed | Thiazide Diuretics Dose changed | Adrenergic beta-Antagonists Dose changed | Cholecalciferol Dose changed | Ergocalciferol Dose changed
Item
change in dose (within 8 weeks) of fibrates, niacin, ace inhibitors, angiotensin receptor blockers, thiazide diuretics, beta-blockers, cholecalciferol or ergocalciferol
boolean
C1449704 (UMLS CUI [1,1])
C1608430 (UMLS CUI [1,2])
C0027996 (UMLS CUI [2,1])
C1608430 (UMLS CUI [2,2])
C0003015 (UMLS CUI [3,1])
C1608430 (UMLS CUI [3,2])
C0521942 (UMLS CUI [4,1])
C1608430 (UMLS CUI [4,2])
C0012802 (UMLS CUI [5,1])
C1608430 (UMLS CUI [5,2])
C0001645 (UMLS CUI [6,1])
C1608430 (UMLS CUI [6,2])
C0008318 (UMLS CUI [7,1])
C1608430 (UMLS CUI [7,2])
C0014695 (UMLS CUI [8,1])
C1608430 (UMLS CUI [8,2])
Urinary Incontinence
Item
incontinent of urine
boolean
C0042024 (UMLS CUI [1])
Malignant Neoplasms | Exception Skin carcinoma
Item
cancer (other than skin cancer) within 5 years
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
Tuberculosis
Item
tuberculosis
boolean
C0041296 (UMLS CUI [1])
Sarcoidosis
Item
sarcoidosis
boolean
C0036202 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial